产品
  • 产品
  • 供应商
  • 采购
  • 资讯
  • 会展
首页 制药产品大全 中间体 2641451-76-3

2641451-76-3

2025-05-30
2641451-76-3
企业标准
工业级

产品详情

2641451-76-3
医药中间体
2641451-76-3
企业标准
工业级
RMC6236的中间体
中国,亚洲

产品描述

主要销售市场:中国、亚洲
补充信息:
根据查询,"2641451-76-3"是百时美施贵宝(BMS)研发的一款KRAS G12C抑制剂(BMS-986439),其分子式为C29H33F3N6O5S,CAS号为2641451-76-3。该化合物是靶向抗癌药物,通过与KRAS G12C突变蛋白共价结合,抑制其活性,用于治疗非小细胞肺癌(NSCLC)等恶性肿瘤。目前处于临床研究阶段,常与其他药物(如PD-1抑制剂)联用。需注意其作为实验性药物,具体疗效和安全性需进一步验证。(300字符)
无锡恩桥医药科技有限公司
访问店铺
注册资本
公司地址
联系人

公司简介

Enbridge PharmTech Co., Ltd. founded in 2013 is an innovative company integrated with R&D, manufacturing, marketing and distribution of intermediates and fine chemicals, mainly used to pharmaceutical, health care products, cosmetics, pesticide and electronic chemicals. Our core services also include CRO service and CDMO service.Enbridge PharmTech has one R&D center and one manufacturing base. R&D center is equipped with good organic synthesis and analytical instruments. In our production base, we have large-scale reactors which cover various SS/ Glass Lined reactors capable of conducting high pressure, high temperature and low temperature reactions. We have the production capability from kilogram to ton. The company has established a sophisticated marketing network and its products are exported to foreign countries and regions, such as USA, South Korea, Japan, India and Europe etc.“High-quality products, cost-effective price, stable supply, fast delivery, best reputation and professional service” is the managing motto of our company. We sincerely hope to establish stable, strategic and long-term business relationship with suppliers and customers home and abroad to pursue more brighter future together.Thanks for supporting EnBridge and we are committed to moving forward together with our partners!
业务类型:
成立日期:
年营业额:
主营产品类别: